HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

As Chief Technology Officer, Beckett will be responsible for leading the Velo3D Research and Development and Informational Technology organizations as well as oversee the implementation of advanced ...

Medrio, a global leader in clinical trial technology, today announced the release of AI-enabled reporting, an innovative new capability available within Medrio CDMS/EDC. Medrio's AI-enabled reporting ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

This was corrected on 01/05/2025 at 1:03 AM. The revised post deletes Q4 and FY24 product revenue consensus ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...